TY - JOUR
T1 - Arterial Hypertension in Women
T2 - State of the Art and Knowledge Gaps
AU - Chapman, Niamh
AU - Ching, Siew M.
AU - Konradi, Aleksandra O.
AU - Nuyt, Anne Monique
AU - Khan, Taskeen
AU - Twumasi-Ankrah, Betty
AU - Cho, Eun J.
AU - Schutte, Aletta E.
AU - Touyz, Rhian M.
AU - Steckelings, U. Muscha
AU - Brewster, Lizzy M.
N1 - Publisher Copyright:
© 2023 American Heart Association, Inc.
PY - 2023/6/1
Y1 - 2023/6/1
N2 - Hypertension is the leading risk factor for cardiovascular disease and premature death among women globally. However, there is a fundamental lack of knowledge regarding the sex-specific pathophysiology of the condition. In addition, risk factors for hypertension and cardiovascular disease unique to women or female sex are insufficiently acknowledged in clinical guidelines. This review summarizes the existing evidence on women and female-specific risk factors and clinical management of hypertension, to identify critical knowledge gaps relevant to research, clinical practice, and women's heart health awareness. Female-specific risk factors relate not only to reproduction, such as the association of gynecological conditions, adverse pregnancy outcomes or menopause with hypertension, but also to the specific roles of women in society and science, such as gender differences in received medical care and the underrepresentation of women in both the science workforce and as participants in research, which contribute to the limited evidence-based, gender- or sex-specific recommendations. A key point is that the development of hypertension starts in young, premenopausal women, often in association with disorders of reproductive organs, and therefore needs to be managed early in life to prevent future cardiovascular disease. Considering the lower blood pressure levels at which cardiovascular disease occurs, thresholds for diagnosis and treatment of hypertension may need to be lower for women.
AB - Hypertension is the leading risk factor for cardiovascular disease and premature death among women globally. However, there is a fundamental lack of knowledge regarding the sex-specific pathophysiology of the condition. In addition, risk factors for hypertension and cardiovascular disease unique to women or female sex are insufficiently acknowledged in clinical guidelines. This review summarizes the existing evidence on women and female-specific risk factors and clinical management of hypertension, to identify critical knowledge gaps relevant to research, clinical practice, and women's heart health awareness. Female-specific risk factors relate not only to reproduction, such as the association of gynecological conditions, adverse pregnancy outcomes or menopause with hypertension, but also to the specific roles of women in society and science, such as gender differences in received medical care and the underrepresentation of women in both the science workforce and as participants in research, which contribute to the limited evidence-based, gender- or sex-specific recommendations. A key point is that the development of hypertension starts in young, premenopausal women, often in association with disorders of reproductive organs, and therefore needs to be managed early in life to prevent future cardiovascular disease. Considering the lower blood pressure levels at which cardiovascular disease occurs, thresholds for diagnosis and treatment of hypertension may need to be lower for women.
KW - cardiometabolic risk factors
KW - cardiovascular disease
KW - gynecological disease
KW - hypertension
KW - menopause
KW - pregnancy
KW - women
UR - http://www.scopus.com/inward/record.url?scp=85159109803&partnerID=8YFLogxK
U2 - 10.1161/HYPERTENSIONAHA.122.20448
DO - 10.1161/HYPERTENSIONAHA.122.20448
M3 - Review article
C2 - 36919603
AN - SCOPUS:85159109803
SN - 0194-911X
VL - 80
SP - 1140
EP - 1149
JO - Hypertension
JF - Hypertension
IS - 6
ER -